These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 12656440)
1. Coronary care physician 1994-2000 adherence to 1993 National Cholesterol Education Program diet and lipid recommendations. Banks T; Ali N J Natl Med Assoc; 2001 Mar; 93(3):87-91. PubMed ID: 12656440 [TBL] [Abstract][Full Text] [Related]
2. Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines. Frolkis JP; Zyzanski SJ; Schwartz JM; Suhan PS Circulation; 1998 Sep; 98(9):851-5. PubMed ID: 9738639 [TBL] [Abstract][Full Text] [Related]
3. Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative. LaBresh KA; Owen P; Alteri C; Reilly S; Albright PS; Hordes AR; Shaftel PA; Noonan TE; Stoukides CA; Kaul AF Am J Cardiol; 2000 Feb; 85(3A):23A-29A. PubMed ID: 10695704 [TBL] [Abstract][Full Text] [Related]
4. Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey. Persell SD; Zei C; Cameron KA; Zielinski M; Lloyd-Jones DM Arch Intern Med; 2010 Mar; 170(5):470-7. PubMed ID: 20212185 [TBL] [Abstract][Full Text] [Related]
5. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy. Allison TG; Squires RW; Johnson BD; Gau GT Mayo Clin Proc; 1999 May; 74(5):466-73. PubMed ID: 10319076 [TBL] [Abstract][Full Text] [Related]
6. Accuracy of statin assignment using the 2013 AHA/ACC Cholesterol Guideline versus the 2001 NCEP ATP III guideline: correlation with atherosclerotic plaque imaging. Johnson KM; Dowe DA J Am Coll Cardiol; 2014 Sep; 64(9):910-9. PubMed ID: 25169177 [TBL] [Abstract][Full Text] [Related]
7. The US National Cholesterol Education Program. Adult treatment guidelines. Hulley SB Drugs; 1988; 36 Suppl 3():100-4. PubMed ID: 3254822 [TBL] [Abstract][Full Text] [Related]
8. Translating cholesterol guidelines into primary care practice: a multimodal cluster randomized trial. Eaton CB; Parker DR; Borkan J; McMurray J; Roberts MB; Lu B; Goldman R; Ahern DK Ann Fam Med; 2011; 9(6):528-37. PubMed ID: 22084264 [TBL] [Abstract][Full Text] [Related]
9. Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines. Danias PG; Silverman DI Circulation; 1999 Jun; 99(25):3325-6. PubMed ID: 10385514 [No Abstract] [Full Text] [Related]
10. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57). Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333 [TBL] [Abstract][Full Text] [Related]
11. [Guidelines of lipid therapy translation into clinical practice]. Rosenberg M; Haass M Internist (Berl); 2005 May; 46 Suppl 1():S11-7. PubMed ID: 15864508 [TBL] [Abstract][Full Text] [Related]
12. Increased statin eligibility based on ACC/AHA versus NCEP guidelines for high cholesterol management in Chile. EcheverrÃa G; Dussaillant C; Villarroel L; Rigotti A J Clin Lipidol; 2016; 10(1):192-8.e1. PubMed ID: 26892136 [TBL] [Abstract][Full Text] [Related]
13. Perceptions about the management of dyslipidaemia among physicians in Jamaica and Trinidad. Monsanto HA; Prann M; Quijada JG West Indian Med J; 2007 Sep; 56(4):334-40. PubMed ID: 18198738 [TBL] [Abstract][Full Text] [Related]
14. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Davidson MH; Maki KC; Pearson TA; Pasternak RC; Deedwania PC; McKenney JM; Fonarow GC; Maron DJ; Ansell BJ; Clark LT; Ballantyne CM Am J Cardiol; 2005 Aug; 96(4):556-63. PubMed ID: 16098311 [TBL] [Abstract][Full Text] [Related]
15. Rationale for aggressive lipid lowering in high-risk patients. Cohen JD J Am Osteopath Assoc; 2011 Apr; 111(4 Suppl 3):eS7-12. PubMed ID: 21593473 [TBL] [Abstract][Full Text] [Related]
16. The cost of treating dyslipidaemia using National Cholesterol Education Program (NCEP) guidelines. McKenney JM Pharmacoeconomics; 1998; 14 Suppl 3():19-28. PubMed ID: 10346425 [TBL] [Abstract][Full Text] [Related]
17. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III. Talbert RL Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of the National Cholesterol Education Program Step I diet. A randomized trial incorporating quick-service foods. Davidson MH; Kong JC; Drennan KB; Story K; Anderson GH Arch Intern Med; 1996 Feb; 156(3):305-12. PubMed ID: 8572841 [TBL] [Abstract][Full Text] [Related]
19. Patterns and effectiveness of lipid-lowering therapies in a managed care environment. Meyer JW; Schultz JS; O'Donnell JC; Patel PA; Sasane RM Value Health; 2005; 8(5):601-12. PubMed ID: 16176498 [TBL] [Abstract][Full Text] [Related]
20. Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease. McBride P; Schrott HG; Plane MB; Underbakke G; Brown RL Arch Intern Med; 1998 Jun; 158(11):1238-44. PubMed ID: 9625403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]